Protection of dopamine neurons by bone marrow stromal cells

Brain Research

Volumn 1186, Issue 1, 2007, Pages 48-55

  Shintani, Aki ^a   Nakao, Naoyuki ^a   Kakishita, Koji ^a   Itakura, Toru ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell therapy; Dopamine neuron; Neurotrophic factor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STROMA CELL;

ANIMALS; BIOLOGICAL FACTORS; BONE MARROW CELLS; BRAIN TISSUE TRANSPLANTATION; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; DOPAMINE; FETAL TISSUE TRANSPLANTATION; GRAFT SURVIVAL; MALE; MESENCEPHALON; MICE; NEOSTRIATUM; NEURONS; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; STROMAL CELLS;

ANIMALIA; RATTUS;

EID: 37649019741     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.09.086     Document Type: Article

References (55)

1. Abercrombie M. Estimation of nuclear population from microtome sections. Anat. Rec. 94 (1946) 239-247
2. Bianco P., Riminucci M., Gronthos S., and Gehron R.P. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19 (2001) 180-192
3. Bjorklund A., and Lindvall O. Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 3 (2000) 537-544
4. Bjorklund A., Rosenblad C., Winkler C., and Kirik D. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol. Dis. 4 (1997) 186-200
5. Brundin P., Pogarell O., Hagell P., Piccini P., Widner H., Schrag A., Kupsch A., Crabb L., Odin P., Gustavii B., Bjorklund A., Brooks D.J., Marsden C.D., Oertel W.H., Quinn N.P., Rehncrona S., and Lindvall O. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 123 (2000) 1380-1390
6. Chen J., Sanberg P.R., Li Y., Wang L., Lu M., Willing A.E., Sanchez-Ramos J., and Chopp M. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32 (2001) 2682-2688
7. Chen J., Li Y., Wang L., Lu M., Zhang X., and Chopp M. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J. Neurol. Sci. 15 (2001) 49-57
8. Chen J., Li Y., Wang L., Lu M., and Chopp M. Caspase inhibition by Z-VAD increases the survival of grafted bone marrow cells and improves functional outcome after MCAo in rats. J. Neurol. Sci. 15 (2002) 17-24
9. Chen J., Zhang Z.G., Li Y., Wang L., Xu Y.X., Gautam S.C., Lu M., Zhu Z., and Chopp M. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ. Res. 92 (2003) 692-699
10. Freed C.R., Breeze R.E., Rosenberg N.J., Schneck S.A., Kriek E., Qi J.X., Lone T., Zhang Y.B., Snyder J.A., and Wells T.H. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N. Engl. J. Med. 327 (1992) 1549-1555
11. Freeman T.B., Olanow C.W., Hauser R.A., Nauert G.M., Smith D.A., Borlongan C.V., Sanberg P.R., Holt D.A., Kordower J.G., Vingerhoets F.J.G., Snow B.J., Calne D., and Gauger L.L. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38 (1995) 379-388
12. Frodl E.M., Nakao N., and Brundin P. Lazaroids improve the survival of cultured rat embryonic mesencephalic neurones. Neuroreport 5 (1994) 2393-2396
13. Hagell P., Schrag A., Piccini P., Jahanshahi M., Brown R., Rehncrona S., Widner H., Brundin P., Rothwell J.C., Odin P., Wenning G.K., Morrish P., Gustavii B., Bjorklund A., Brooks D.J., Marsden C.D., Quinn N.P., and Lindvall O. Sequential bilateral transplantation in Parkinson's disease: effects of the second graft. Brain 122 (1999) 11121-11132
14. Horwitz E.M., Prockop D.J., Fitzpatrik L.A., Koo W.W., Gordon P.L., Neel M.D., Sussman M., Orchard P., Marx J.C., Pyeritz R.E., and Brenner M.K. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 5 (1999) 309-313
15. Horwitz E.M., Prockop D.J., Gordon P.L., Koo W.W., Fitzpatrik L.A., Neel M.D., McCarville M.E., Orchard P.J., Marx J.C., Pyeritz R.E., and Brenner M.K. Clinical response to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97 (2001) 1227-12231
16. Horwitz E.M., Gordon P.L., Koo W.W., Marx J.C., Neel M.D., McNall R.Y., Muul L., and Hofmann T. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl. Acad. Sci. U. S. A. 25 (2002) 8932-8937
17. Hyman C., Hoffer B., Barde Y., Juhasz M., Yancopoulos G.D., Squinto S.P., and Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350 (1991) 230-233
18. Hyman C., Juhasz M., Jackson C., Wright P., Ip N.Y., and Lindsay R.M. Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J. Neurosci. 14 (1994) 335-347
19. Kakishita K., Nakao N., Sakuragawa N., and Itakura T. Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopamine lesions. Brain Res. 980 (2003) 48-56
20. Kinnaird T., Stabile E., Burnett M.S., and Epstein S.E. Bone-marrow-derived cells for enhancing collateral development: mechanism, animal data, and initial clinical experience. Cir. Res. 95 (2004) 354-363
21. Kordower J.H., Freeman T.B., Snow B.J., Vingerhoets F.J., Mufson E.J., Sanberg P.R., Hauser R.A., Smith D.A., Nauert G.M., and Perl D.P. Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332 (1995) 1118-11124
22. Kordower J.H., Rosenstein J.M., Collier T.J., Burke M.A., Chen E.Y., Li J.M., Martel L., Levy A.E., Mufson E.J., Freeman T.B., and Olanow C.W. Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J. Comp. Neurol. 370 (1996) 203-230
23. Li Y., Chen J., Chen X.G., Wang L., Gautam S.C., Xu Y.X., Katakowski M., Zhang L.J., Lu M., Janakiraman N., and Chopp M. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 27 (2002) 514-523
24. Lin L.F., Doherty D., Lile J., Becktesh S., and Collins F. A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260 (1993) 1130-1132
25. Lindvall O., Brundin P., Widner H., Rehncrona S., Gustavii B., Frackowiak R., Leenders K.L., Sawle G., Rothwell J.C., Marsden C.D., and Bjorklund A. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247 (1990) 574-577
26. Lindvall O., Sawle G., Widner H., Rothwell J.C., Bjorklund A., Brooks D., Brundin P., Frackowiak R., Marsden C.D., and Odin P. Evidence of long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35 (1994) 172-180
27. Lu D., Li Y., Wang L., Chen J., Mahmood A., and Chopp M. Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury. J. Neurotrauma 18 (2001) 813-819
28. Lu D., Li Y., Mahmood A., Wang L., Rafiq T., and Chopp M. Neural and marrow-derived stromal cell sphere transplantation in a rat model of traumatic brain injury. J. Neurosurg. 97 (2002) 935-940
29. Mahmood A., Lu D., Wang L., Li Y., Lu M., Chen J.L., and Chopp M. Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells. Neurosurgery 49 (2001) 1196-1203
30. Mahmood A., Lu D., Yi L., Chen J.L., and Chopp M. Intracranial bone marrow transplantation after traumatic brain injury improving functional outcome in adult rats. J. Neurosurg. 94 (2001) 589-595
31. Mahmood A., Lu D., Wang L., and Chopp M. Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury. J. Neurotrauma 19 (2002) 1609-1617
32. Mahmood A., Lu D., Lu M., and Chopp M. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 53 (2003) 697-702
33. Mahmood A., Lu D., and Chopp M. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J. Neurotrauma 21 (2004) 33-39
34. Mahmood A., Lu D., Qu C., Goussev A., and Chopp M. Long-term recovery after bone marrow stromal cell treatment of traumatic brain injury in rats. J. Neurosurg. 104 (2006) 272-277
35. Mayer E., Dunnett S.B., Pellitteri R., and Fawcett J.W. Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons. I. Effects in vivo. Neuroscience 56 (1993) 379-388
36. McKay B.S., Goodman B., Falk T., and Sherman S.J. Retinal pigment epithelial cell transplantation could provide trophic support in Parkinson's disease: results from an in vitro model system. Exp. Neurol. 201 (2006) 234-243
37. Nakao N., Frodl E.M., Duan W.-M., Widner H., and Brundin P. Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 12408-12412
38. Nakao N., Frodl E.M., Duan W.-M., Widner H., and Brundin P. Overexpressing CuZn-superoxide dismutase enhances transplanted neurons in a rat model of Parkinson's disease. Nat. Med. 1 (1995) 226-231
39. Nakao N., Nakai K., and Itakura T. Metabolic inhibition enhances selective toxicity of L-DOPA toward mesencephalic dopamine neurons in vitro. Brain Res. 777 (1997) 202-209
40. Nakao N., Ogura M., Nakai K., and Itakura T. Intrastriatal mesencephalic grafts affect neuronal activity in basal ganglia nuclei and their target structures in a rat model of Parkinson's disease. J. Neurosci. 18 (1998) 1806-1817
41. Nakao N., Yokote H., Nakai K., and Itakura T. Promotion of survival and regeneration of nigral dopamine neurons in a rat model of Parkinson's disease after implantation of embryonal carcinoma-derived neurons genetically engineered to produce glial cell line-derived neurotrophic factor. J. Neurosurg. 92 (2000) 659-670
42. Nakao N., Shintani-Mizushima A., Kakishita K., and Itakura T. The ability of human sympathetic neurons to synthesize and store dopamine: a potential mechanism for the clinical effect of sympathetic neuron autografts in patients with Parkinson's disease. Exp. Neurol. 188 (2004) 65-73
43. Ohta M., Suzuki Y., Noda T., Ejiri Y., Dezawa M., Kataoka K., Chou H., Ishikawa N., Matsumoto N., Iwwashita Y., Mizuta E., Kuno S., and Ide C. Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp. Neurol. 187 (2004) 266-278
44. +: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells. J. Neurosci. Res. 34 (1993) 382-393
45. Peschanski M., Defer G., N'Guyen J.P., Ricolfi F., Monfort J.C., Remy P., Geny C., Samson Y., Hantraye P., and Jeny R. Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. Brain 117 (1994) 487-499
46. Pittenger M.F., and Martin B.J. Mesenchymal stem cells and their potential use of cardiac therapeutics. Cir. Res. 95 (2004) 9-20
47. Reyes M., and Verfaillie C.M. Characterization of multipotent adult progenitor cells, a subpopulation of mesenchymal stem cells. Ann. N Y Acad. Sci. 938 (2001) 231-233
48. Rosenzweig A. Cardiac cell therapy - mixed results from mixed cells. N. Engl. J. Med. 355 (2006) 1274-1277
49. Strauer B.E., Brehm M., Zeus T., Kostering M., Hernandez A., Sorg R.V., Kogler G., and Wernet P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106 (2002) 1913-1918
50. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., Amano K., Kishimoto Y., Yoshimoto K., Akashi H., Shimada K., Iwasaka T., Imaizumi T., and for the Therapeutic Angiogenesis using Cell Transplantation (tact) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360 (2002) 427-435
51. Toledo-Aral J.J., Méndez-Ferrer A., Pardal R., Echevarría M., and López-Barneo J. Trophic restoration of the nigrostriatal dopaminergic pathway in long-term carotid body-grafted parkinsonian rats. J. Neurosci. 23 (2003) 141-148
52. Ungerstedt U., and Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24 (1970) 486-493
53. Villadiego J., Méndez-Ferrer S., Valdés-Sánchez T., Silos-Santiago I., Fariñas I., López-Barneo J., and Toledo-Aral J.J. Selective glial cell line-derived neurotrophic factor production in adult dopaminergic carotid body cells in situ and after intrastriatal transplantation. J. Neurosci. 25 (2005) 4091-4098
54. Wenning G.K., Odin P., Morrish P., Rehncrona S., Widner H., Brundin P., Rothwell J.C., Brown R., Gustavii B., Hagell P., Jahanshahi M., Sawle G., Bjorklund A., Brooks D.J., Marsden C.D., Quinn N.P., and Lindvall O. Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol. 42 (1997) 95-107
55. Wu S., Suzuki Y., Ejiri Y., Noda T., Bai H., Kitada M., Kataoka K., Ohata M., Chou H., and Ide C. Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord. J. Neurosci. Res. 72 (2003) 343-351